-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Brokerages Set Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Price Target at $351.67
Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating, ten have issued a buy rating and one has issued […]
Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating, ten have issued a buy rating and one has issued […]
